The National Institutes of Health within the Department of Health and Human Services is seeking to procure Revio SMRT Cells and Sequencing Reagents through this solicitation opportunity. This procurement falls under the Analytical Laboratory Instrument Manufacturing NAICS category and is classified under the Drugs and Biologicals PSC code, indicating the specialized nature of these advanced sequencing materials. The solicitation was posted on August 25, 2025, with a response deadline of September 5, 2025, providing potential contractors with an 11-day window to prepare and submit their proposals. The procurement appears to be for laboratory consumables essential for DNA sequencing operations using Pacific Biosciences' Single Molecule Real-Time (SMRT) sequencing technology. The evaluation criteria and specific contract requirements are not detailed in the available information, though the nature of the goods suggests highly specialized technical specifications will be required.

This procurement does not utilize any set-aside designations, making it open to full and open competition among all eligible contractors. No incumbent contractors or current service providers are identified in the solicitation notice. The award value, budget range, and specific quantities of SMRT cells and reagents required are not specified in the available documentation. The timeline for service delivery or product shipment is also not indicated in the current solicitation details. The place of performance is not explicitly stated, though given the NIH's role as the procuring agency, delivery would likely be to NIH facilities or designated research locations within the Department of Health and Human Services network.

Revio SMRT Cells and Sequencing Reagents

Opportunity facts

About this opportunity

Notice text

Work this opportunity on GovTribe